| Raffaele Bruno, MD | |
|
Lahey Clinic, 41 Mall Rd., Burlington, MA 01805-0001 | |
| (781) 744-8000 | |
| (781) 744-1099 |
| Full Name | Raffaele Bruno |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 37 Years |
| Location | Lahey Clinic, Burlington, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215091905 | NPI | - | NPPES |
| 3081176 | Medicaid | MA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lahey Clinic Inc | 2264336528 | 1211 |
News Archive
HASCO Medical, Inc., www.HascoMed.com a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, is pleased to announce that the Company has completed the acquisition of all of the outstanding capital stock of Ride-Away Handicap Equipment Corp., a closely-held New Hampshire corporation (Ride-Away).
AstraZeneca today announced the first patient randomized in a Phase 3 clinical trial for selumetinib, an oral, potent, selective MEK inhibitor, being investigated as second-line therapy in patients with advanced or metastatic non-small-cell lung cancer whose tumors are KRAS mutation-positive.
On the World Blood Donors Day, OrSense Ltd., developer of monitors for non-invasive measurements of key blood parameters, presents its non-invasive hemoglobin (Hb) monitor, which holds potential to enhance recruitment and retention of blood donors.
Numerical data sometimes reveal facts that are otherwise concealed within an onslaught of information from an overwhelming number of sources.
Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).
› Verified 3 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538194980 PECOS PAC ID: 2264336528 Enrollment ID: O20031120000097 |
News Archive
HASCO Medical, Inc., www.HascoMed.com a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, is pleased to announce that the Company has completed the acquisition of all of the outstanding capital stock of Ride-Away Handicap Equipment Corp., a closely-held New Hampshire corporation (Ride-Away).
AstraZeneca today announced the first patient randomized in a Phase 3 clinical trial for selumetinib, an oral, potent, selective MEK inhibitor, being investigated as second-line therapy in patients with advanced or metastatic non-small-cell lung cancer whose tumors are KRAS mutation-positive.
On the World Blood Donors Day, OrSense Ltd., developer of monitors for non-invasive measurements of key blood parameters, presents its non-invasive hemoglobin (Hb) monitor, which holds potential to enhance recruitment and retention of blood donors.
Numerical data sometimes reveal facts that are otherwise concealed within an onslaught of information from an overwhelming number of sources.
Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).
› Verified 3 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063447316 PECOS PAC ID: 2264336528 Enrollment ID: O20040629001269 |
News Archive
HASCO Medical, Inc., www.HascoMed.com a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, is pleased to announce that the Company has completed the acquisition of all of the outstanding capital stock of Ride-Away Handicap Equipment Corp., a closely-held New Hampshire corporation (Ride-Away).
AstraZeneca today announced the first patient randomized in a Phase 3 clinical trial for selumetinib, an oral, potent, selective MEK inhibitor, being investigated as second-line therapy in patients with advanced or metastatic non-small-cell lung cancer whose tumors are KRAS mutation-positive.
On the World Blood Donors Day, OrSense Ltd., developer of monitors for non-invasive measurements of key blood parameters, presents its non-invasive hemoglobin (Hb) monitor, which holds potential to enhance recruitment and retention of blood donors.
Numerical data sometimes reveal facts that are otherwise concealed within an onslaught of information from an overwhelming number of sources.
Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Raffaele Bruno, MD Lahey Clinic, 41 Mall Rd., Burlington, MA 01805-0001 Ph: (781) 744-8564 | Raffaele Bruno, MD Lahey Clinic, 41 Mall Rd., Burlington, MA 01805-0001 Ph: (781) 744-8000 |
News Archive
HASCO Medical, Inc., www.HascoMed.com a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, is pleased to announce that the Company has completed the acquisition of all of the outstanding capital stock of Ride-Away Handicap Equipment Corp., a closely-held New Hampshire corporation (Ride-Away).
AstraZeneca today announced the first patient randomized in a Phase 3 clinical trial for selumetinib, an oral, potent, selective MEK inhibitor, being investigated as second-line therapy in patients with advanced or metastatic non-small-cell lung cancer whose tumors are KRAS mutation-positive.
On the World Blood Donors Day, OrSense Ltd., developer of monitors for non-invasive measurements of key blood parameters, presents its non-invasive hemoglobin (Hb) monitor, which holds potential to enhance recruitment and retention of blood donors.
Numerical data sometimes reveal facts that are otherwise concealed within an onslaught of information from an overwhelming number of sources.
Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).
› Verified 3 days ago
Temitope Patricia Awosogba, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8560 Fax: 781-744-5398 | |
Marc F Freedman, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 101 Cambridge St, Burlington, MA 01803 Phone: 781-272-4667 | |
Dr. Anju T Nayar, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Cambridge St, Burlington, MA 01803 Phone: 781-272-4667 Fax: 781-270-4196 | |
Nidha P. Mattappally, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Lahey Hospital And Medical Center, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8560 Fax: 781-744-5398 | |
Shilpa Malhotra, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 20 Wall St, Burlington, MA 01803 Phone: 781-221-2940 | |
Valena J Wright, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Lahey Clinic, 41 Mall Rd., Burlington, MA 01805 Phone: 781-744-8000 Fax: 781-744-5349 | |
Dr. Cynthia Ann Rasmussen, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 20 Wall St, Harvard Vanguard, Burlington, MA 01803 Phone: 781-221-2940 Fax: 781-221-2854 |